City

Hong Kong (1)

Condition

Elevated Serum Lipoprotein(a) (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Amgen (1)

Collaborator

Intervention

olpasiran (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

elevated serum lipoprotein(a)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Elevated Serum Lipoprotein(a) Trial in Hong Kong (Olpasiran)

Completed

Elevated Serum Lipoprotein(a)

Olpasiran

Hong Kong, HK, Hong Kong

Queen Mary Hospital

Mar 30, 2022